Related Experiment Video
Updated: Aug 16, 2026
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Pseudomonas aeruginosa infections in the intensive care unit
1Rush University, Chicago, Illinois, USA. john_p_quinn@rush.edu
Abstract:
Pseudomonas aeruginosa is a common and highly lethal agent of nosocomial infection, especially among intensive care unit patients. It is widespread in the environment and commonly recovered from water in nature and in hospital settings. P. aeruginosa is endowed with a formidable array of virulence factors that facilitate attachment to host cells, tissue invasion, and systemic disease. It is intrinsically resistant to many commonly employed antibiotics due to a complex variety of mechanisms briefly reviewed here. Resistance to fluoroquinolones appears to be increasing particularly rapidly. Recent advances in the understanding of the molecular biology of this organism have shed considerable light on its ability to form biofilms, which facilitate adherence, especially in cystic fibrosis patients, and confer resistance to clearance by host immune mechanisms and antimicrobial killing. Treatment studies have demonstrated a significant risk of emergence of resistance during therapy with a variety of agents. Several studies suggest that two drugs are better than one for therapy of serious infections, although dual therapy does not always prevent emergence of resistant strains. The sequencing of the genome will lead to new understanding of pathogenesis and may identify new drug targets.
Insights
Pseudomonas aeruginosa causes lethal hospital infections and is resistant to antibiotics. Understanding its biofilms and genetic makeup may reveal new ways to combat this dangerous pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Pseudomonas aeruginosa is a frequent cause of severe nosocomial infections, particularly in intensive care units.
- This opportunistic pathogen is ubiquitous in the environment and possesses numerous virulence factors.
- Intrinsic antibiotic resistance mechanisms contribute to treatment challenges.
Purpose of the Study:
- To review the virulence factors, resistance mechanisms, and biofilm formation of Pseudomonas aeruginosa.
- To discuss the implications of genomic sequencing for understanding pathogenesis and identifying drug targets.
- To highlight challenges in treating P. aeruginosa infections, including emerging resistance.
Main Methods:
- Review of existing literature on Pseudomonas aeruginosa.
- Analysis of virulence factors and antibiotic resistance mechanisms.
- Discussion of biofilm formation and its role in pathogenesis.
- Consideration of treatment strategies and emerging resistance patterns.
Main Results:
- P. aeruginosa utilizes diverse virulence factors for host cell attachment, invasion, and systemic disease.
- Intrinsic resistance to antibiotics is common, with rapidly increasing resistance to fluoroquinolones.
- Biofilm formation enhances adherence and confers resistance to immune clearance and antimicrobial agents.
- Emergence of resistance during therapy is a significant risk, even with dual drug therapy.
Conclusions:
- Pseudomonas aeruginosa poses a significant threat due to its virulence and complex resistance mechanisms.
- Understanding biofilm formation is crucial for combating P. aeruginosa infections, especially in cystic fibrosis.
- Genomic insights offer potential for developing novel therapeutic targets and strategies.
- Effective treatment requires careful consideration of antibiotic resistance and combination therapies.
Related Concept Videos
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Pneumonia III: Complications and Assessment